Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Cardiovascular Diseases

• A Randomized, Single-blind, Controlled Clinical Study of Cardiomyopeptidin on Improving Ischemia-reperfusion Injury in Patients With Acute ST-segment Elevation Myocardial Infarction After Primary PCI
• Effects of NT-0796 in Obese Participants at Risk of Cardiovascular Disease
• Cardiovascular Effects of a Healthy Dietary Pattern Containing Eggs
• Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation
• Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
• Optimal Blood Pressure Treatment Thresholds Postpartum
• Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms
• YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis
• Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE
• Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 Diabetes
• The Effect of Allopurinol on the Risk of Cardiovascular Events in Patients With Cardiovascular Risk
• A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
• Semaglutide and Vascular Regeneration
• Study of Novel PET Tracer Gallium [68Ga]/ Fluorine [18F] -FAPI-04 in the Diagnosis of Cardiovascular Diseases
• To Evaluate the Safety and Efficacy of NVP-2203 Tablet in Patients
• VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)
• A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Disease
• An ADME Study of [14C]AZD0780 in Healthy Male Subjects
• Active Screening of Arterial Hypertension by Community Outreach Workers in the Cayenne Metropolitan Area to Reduce the Incidence of Cardiovascular Disease
• A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
• Effect of Sublingually Generated S-nitroso-N-acetylcysteine on Systemic Blood Pressure.
• High Risk Population of Cardiovascular Disease in Hubei Province Screening and Intervention Program
• Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments
• Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients
• Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
• The Effect of Probiotics on Depression Syndrome and Risk Factors of Cardiovascular Disease in Hemodialysis Patients
• Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial
• Effect of MRA on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia
• A First-in-human Study of YN001 in Healthy Volunteers
• COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes
• ETA and AT1 Antagonism in ANCA-vasculitis (SPARVASC)
• A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia
• Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial
• Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy
• Study of Early Pharmaceutical Intervention for Cardiovascular Disease Prevention in Stage 1 Hypertension
• A Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With TQJ230 on Major Cardiovascular Events in Patients With Cardiovascular Disease
• Genetic-Dependent Cardiovascular Response to PPAR-Alpha Agonist Fenofibrate
• Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events
• The Effect of Aspirin on HIV Disease Progression Among HIV- Infected Individuals Initiating Anti- Retroviral Therapy
• The Impact of "First-Line" Rhythm Therapy on AF Progression
• Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
• Testing P2Y12 Platelet Inhibitors Generics Beyond Bioequivalence
• Comparing Perclose to Statseal in Conjunction With Perclose in Femoral 6 French Arteriotomy Closure
• Effects of Dengzhanxixin Capsule on Platelet Function in Individuals at High Risk for Cardiovascular Disease
• The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE)
• Effect of Coadministration of Itraconazole on the Pharmacokinetics of CRD-740
• Effectiveness of CRD-740 in Heart Failure
• A Study of VERVE-101 in Patients With Familial Hypercholesterolemia and Cardiovascular Disease
• Propranolol on Post Stroke Immune Status and Infection
• Canagliflozin and Myocardial Micro-perfusion
• Effect of Intensive LDL-cholesterol Targeting for Elderly Patients With Cardiovascular Disease: I-OLD Trial
• A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe Hypertriglyceridemia
• Clinical Study of CMR to Evaluate the Effect of Ivabradine on the Improvement of Left Ventricular Remodeling in STEMI Patients After Primary PCI
• A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Rate of Weekly Lipoprotein Apheresis Sessions in Patients With Hyperlipoproteinemia(a) and Established Cardiovascular Disease in Germany
• EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction
• A Study for Exploring the Efficacy of Naoxintong Capsules in the Treatment of Coronary Atherosclerotic Plaque on the Basis of Optimal Medical Therapy (Aspirin,Statins,Clopidogrel, Etc.): Stage One
• Cholesterol Lowering Via Bempedoic Acid/Ezetimibe, an ACL-Inhibiting Regimen in Acute Coronary Syndrome Study
• Extended-Release Tacrolimus Following Liver Transplantation
• Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease
• Colchicine and Inflammation in Aortic Stenosis
• Cardiovascular Diseases and Diabetes Prevention Programme in Metabolic Syndrome (CDPP)
• A Research Study Looking at the Effect of Food Intake on How the Medicine NN0385-0434 Behaves in the Body of Healthy Participants
• Zinc Effect on Inflammation and Cardiovascular Risk in HIV
• Cardiometabolic Effects of Pecans as a Snack
• MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease
• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation
• A Research Study Looking at How the Medicine NNC0385-0434 Works in the Body of Healthy Japanese Men
• Additive Anti-inflammatory Action for Critically Ill Patients With Cardiovascular Surgery (Xuebijing) IV
• A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease
• Natriuretic Peptide-Renin-Angiotensin-Aldosterone System Rhythm Axis and Nocturnal Blood Pressure
• Baseline Oral Health Study: UnCoVer the Connections to General Health
• Immunomodulation Using VB-201 to Reduce Arterial Inflammation in Treated HIV - VITAL HIV Trial
• A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTOR
• ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase
• Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions
• Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions
• Changes in Weight, Body Composition and Cardiac Risk After Discontinuing Abacavir Treatment in HIV-infected Individuals
• Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
• Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease
• Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support
• Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reduction
• Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction
• Study of Efficacy and Safety of LIB003 in Patient With CVD on Statins Requiring Additional LDL-C Reduction
• Pharmacokinetic and Pharmacodynamic Study of a Novel Sublingual Aspirin Tablet
• The Effects of Iontophoresed Vasoactive Drugs on Cutaneus Blood Flow
• Dapagliflozin Effect on Cardiovascular Outcomes in Haemodialysis for End Stage Renal Disease
• The ALA, DHA and EPA Esters in the Prevention of Cardiovascular Diseases.
• Acute Myocardial Infarction and Unstable Angina Patients With PCSK9 Inhibitor Usage Study
• Wellness Intervention for Smoking and HIV
• Secondhand Tobacco Smoke and Cardiovascular Disease
• Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
• Absolute Bioavailability and ADME Study of [14C]AZD9977 in Healthy Male Subjects
• Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions
• The Role of Statins in the Prevention of Contrast-induced Acute Kidney Injury in Patients With Cardiovascular Diseases
• Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions
• A Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of CKD-333 or Co-administration of CKD-333 and D085 in Healthy Volunteers
• Effects of Ezetimibe Combination Therapy for Patients With Atherosclerotic Cardiovascular Disease; Randomized Comparison of LDL-cholesterol Targeting <70 Versus <55mg/dL; Ez-PAVE Trial
• Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)
• Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors
• Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-333 Low Dose in Healthy Volunteers
• The COVID-RASi Trial (COVID-19)
• Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast Cancer
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese Subjects
• Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses
• The Use of Icosapent Ethyl on Vascular Progenitor Cells in Individuals With Elevated Cardiovascular Risk
• Open-Label Study of 18F-mFBG for Imaging Myocardial Sympathetic Innervation
• Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity
• A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults
• The 3 Years vs 1 Year DAPT After XINSORB BRS Implantation
• A Study to Assess the Effect of Multiple Doses of AZD5718 on Pharmacokinetics of Oral Midazolam in Healthy Subjects
• Diet Quality, Pecans, and Cardiometabolic Health
• Clinical Transfer of a Vulnerable Atherosclerotic Plaque Tracer : 99mTc-cAbVCAM1-5 (ATHENA)
• TRISCEND II Pivotal Trial
• Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers
• Empagliflozin and Cardiac Remodelling in People Without Diabetes
• Effects of CoQ10 on Inflammatory Response in Cardiac Surgery
• Cardio-Cerebrovascular Co-Prevention and Co-Management Based on Internet+
• A Study to Assess the Mass Balance Recovery, Pharmacokinetics, Metabolite Profile and Metabolite Identification of [14C]AZD4831
• Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19
• The Nitrite and Coronary Flow Study
• Impact of T Cells on Age-related Vascular Dysfunction: A Translational Approach
• Contribution of Dolutegravir to Obesity and Cardiovascular Disease
• Impact of PCSK9 Inhibitors on Coronary Microvascular Dysfunction in Patients With Atherosclerotic Cardiovascular Disease Proved by Myocardial Ischemia and Needing Coronarography
• ACE Inhibitors or ARBs Discontinuation in Context of COVID-19 Pandemic
• Asian Diabetes Outcomes Prevention Trial
• Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study
• Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
• Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
• Postpartum Low-Dose Aspirin After Preeclampsia for Optimization of Cardiovascular Risk (PAPVASC)
• Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)
• How Atorvastatin Affects the Gut Flora and Metabolomics?
• Canadian Study of Arterial Inflammation in Patients With Diabetes and Vascular Events: EvaluatioN of Colchicine
• Ertugliflozin: Cardioprotective Effects on Epicardial Fat
• Supplementation of Oil Palm Phenolics to Healthy Participants
• Anti-Inflammatory Drug and Endothelial Function
• Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab (Olmesartan 20 mg/Amlodipine 5 mg/Rosuvastatin 5 or 10 mg) in Hypertension Patients With Low-Intermediate Risk for Cardiovascular Disease
• A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH
• Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
• Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
• Efficacy and Safety of Combination Therapy of Moderate-intensity Statin and Ezetimibe Compared to High-intensity Statin
• Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy Volunteers
• Absorption, Distribution, Metabolism and Excretion of [14C] Labelled BIA 5-1058
• Effect of Liraglutide on the Metabolic Profile in Patients With Type 2 Diabetes and Cardiovascular Disease
• Pistachios Blood Sugar Control, Heart and Gut Health
• Atorvastatin vs Colchicine in Decrease of Troponin I of High Sensitivity in Patients With Rheumatoid Arthritis.
• NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
• Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
• Higher vs. Lower Dose Heparin for PCI
• Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)
• Comparison Between Propofol and Inhalational Anaesthetic Agents on Cardiovascular Outcomes Following Cardiac Surgery
• Assessing the Impact of Lipoprotein (a) Lowering With TQJ230 on Major Cardiovascular Events in Patients With CVD
• Effects of Prolonged Delivery of Nitric Oxide Gas on Plasma Reduction-Oxidation Reactions in Cardiac Surgical Patients
• Iron in Patients With Cardiovascular Disease
• Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease
• Thromboxane Receptor Antagonist to Improve Endothelial Cell Function
• Study Evaluating the Pharmacokinetic and Mass Balance of Single Dose [14C] AZD5718 in Volunteers
• Preventing Adverse Cardiac Events in COPD
• The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) Trial
• The Recovery of Cardiovascular Patients With Depression
• Pharmaco-metabolomic Effects of Statins: METASTATINE
• Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers
• Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes After Hepatitis C Eradication
• Oophorectomy, Estrogen Therapy and Cardiovascular Disease Risk in Young Women
• Aspirin to Target Arterial Events in Chronic Kidney Disease
• Anti-thrombotic Monotherapy in HeartMate 3 Left Ventricular Assist System (LVAS)
• Study to Evaluate the Effects of MEDI6012 on Apolipoprotein B100 Metabolism
• Low- and Moderate-intensity Statin and Clinical Outcome of Primary Prevention in Individuals Aged >75 Years: the SCOPE-75 RCT Study
• Effects of Nitric Oxide on the Endothelium During Hemolysis.
• Cardiovascular Disease Risk in Women With Endometriosis
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 5-1058
• A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease
• Anti-thrombotic Monotherapy With the HeartMate 3 LVAS
• Effect of Evolocumab on Coronary Artery Plaque Volume and Composition by CCTA and Microcalcification by F18-NaF PET
• Local Antioxidant Therapy Vasoconstriction Effects in Different Races
• A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
• The Effect of Local Antioxidant Therapy on Racial Differences in Vasoconstriction
• The Effect of Endothelin and L-Arginine on Racial Differences in Vasoconstriction
• Effect of Puerarin on Heart Health in Men
• The Impact of Statin Holiday in Dialysis Patients Over 70 Years Old on Mental Function, Physical Function and Frailty
• Effect of Saxagliptin and Dapagliflozin on Endothelial Progenitor Cell in Patients With Type 2 Diabetes Mellitus
• Peanuts and Glycemic Control
• Management of Cardiovascular Disease in Kidney Disease (MaCK) Study
• Evaluation of Losartan on Cardiovascular Disease in Patients With Mucopolysaccharidoses IV A and VI
• Effect of Evolocumab on Vascular Function
• A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AMG 890 in Subjects With Elevated Plasma Lipoprotein(a)
• Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM
• A Single-arm Evaluation of the Effect of HCV Treatment on Cardiovascular Disease Risk
• Prospective Comparison of Metolazone Versus Chlorothiazide for Acute Decompensated Heart Failure With Diuretic Resistance
• A Polypill for Secondary Prevention of Ischemic Heart Disease
• People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
• A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men
• Safety of Single Intravenous Administration of S95010 in Human Healthy Volunteers
• Effect of BIA 5 1058 on Cardiac Repolarization
• Are the "Cardiac Benefits" of Empagliflozin Independent of Its Hypoglycemic Activity? (ATRU-4).
• Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
• Prevention of Cardiovascular Disease With Polypill Among Pars Cohort Participants
• A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin
• COMT on Aspirin Platelets Effects (CAPE)
• Drug-drug Interaction Study to Evaluate the Effect of ISIS 681257 on Warfarin
• Red Blood Cell ATP Release and Vascular Function in Humans
• Study of the Effect of Calcifediol Supplementation on Cardiopathic Patients Undergoing Major Orthopedic Surgery (Vitamina D).
• High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes
• Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
• Drug-drug Interaction Study to Evaluate the Effect of ISIS 681257 on Clopidogrel
• Study of ISIS 678354 (AKCEA-APOCIII-LRx) in Participants With Hypertriglyceridemia and Established Cardiovascular Disease (CVD)
• Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults
• Vascular Dysfunction in Hypertensive Postmenopausal Women
• Impact of Statin Therapy on Adaptations to Aerobic Exercise
• Investigating the Lowest Threshold of Vascular Benefits From LDL Cholesterol Lowering in Patients With Stable CV Disease
• Clinical Study of UMOD NKCC2 Interaction on Salt-sensitivity in Hypertension
• Phosphorylcholine PC-mAb Effects in Subjects With Elevated Lipoprotein a
• Sonodynamic Therapy on Patients With Femoropopliteal PAD and Claudication
• Evaluation of the Effect of 10% Lidocaine Spray Undergoing Coronary Artery Bypass Graft Operation
• CRUSHed vs. Uncrushed Prasugrel in STEMI Patients Undergoing PCI
• Hypertonic Saline for Fluid Resuscitation After Cardiac Surgery
• INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
• Rosuvastatin Effect on Atherosclerotic Plaque Metabolism
• Subclinical Cardiovascular Disease in Psoriatic Disease
• Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)
• Effects of Canagliflozin on Intravascular Volume and Hemodynamics
• CES1 Carriers in the PAPI Study
• VOLtage-based Contrast Media AdaptatioN in Coronary Computed Tomography Angiography
• The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM
• A Phase I, Safety Tolerability and Pharmacokinetics of AZD4831 to Treat Cardiovascular Disease
• The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM
• Use of Lexiscan for Myocardial Stress Perfusion Computed Tomography With a 3rd Generation Dual Source CT System
• A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems
• Impact of Evolocumab on the Effects of Clopidogrel in Patients With High On-Treatment Platelet Reactivity
• Vascular Inflammation in Psoriasis - Apremilast
• Fourier Open-label Extension Study in Subjects With Clinically Evident Cardiovascular Disease in Selected European Countries
• MAGENTUM 1 HeartMate 3 LVAS: A Single Center Prospective Controlled Study (MAGENTUM 1)
• Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease
• Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)
• An Extension Trial of Inclisiran Compared to Evolocumab in Participants With Cardiovascular Disease and High Cholesterol
• RAndomized Comparison of Efficacy and Safety of Lipid-lowerING With Statin Monotherapy Versus Statin/Ezetimibe Combination for High-risk Cardiovascular Diseases (RACING Trial)
• Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic Limbs
• Impact of Liraglutide 3.0 on Body Fat Distribution
• Evaluating the Safety and Efficacy of Qishen Granules Among Patients With Chronic Heart Failure
• Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women
• Gene-by-Stress Interactions in Intervention Studies Significance
• The Acute Cardiovascular Effects of Nicotine in E-cigarettes (ACE) Study
• Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease
• Effects of Empagliflozin on Cardiac Structure in Patients With Type 2 Diabetes
• Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
• Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk
• Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant
• Dapagliflozin and Measures of Cardiovascular Autonomic Function in Patients With Type 2 Diabetes (T2D)
• PPARGC1β and CNTN4 Genotype Aspirin Study
• Effect of SNF472 on Progression of Cardiovascular Calcification in End-Stage-Renal-Disease (ESRD) Patients on Hemodialysis (HD)
• Epimedium Prenylflavonoid (EP) Extract for Osteoporosis and Cardiovascular Disease
• The Effect of Anacetrapib on Vascular Function and Arterial Stiffness
• Impact of Extra Virgin Olive Oil Oleocanthal Content on Platelet Reactivity
• The Tolerability of Alprostadil Liposome for Injection in Healthy Adult Volunteers
• The Bleeding With Antithrombotic Therapy Study 2
• Assessment of Global Longitudinal Strain for the Prediction of Anthracycline Induced Cardiotoxicity
• Impact of isoQUercetin and Aspirin on Platelet Function
• Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI
• Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)
• Effect of Trimetazidine During the Primary PCI on Cardiac Function in Patients With ST-elevation Myocardial Infarction
• Effects of Ticagrelor on No-reflow in Patients With Acute ST-segment Elevation Myocardial Infarction
• Investigation of the Atherogenic Effects of Uric Acid-modified in Endothelial Dysfunction and the the Preventional Mechanism by Anthocyanidines
• Living With Statins - Interventional Exercise Study
• STATIN: Web-based Investigation of Side Effects
• CT COMPARE: CT Coronary Angiography to Measure Plaque Reduction
• Effects of Eplerenone on Cardiovascular Disease in HIV (MIRACLE HIV Study)
• Autoimmune Basis for Postural Tachycardia Syndrome
• Lipids, Inflammation, and CV Risk in RA
• A Study to Assess the Safety and Tolerability of Single and Multiple Doses of AZD4831 in Healthy Male Subjects
• Evaluation of a New Thermostable Formulation of FLOLAN in Japanese Subjects
• Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
• What Are the Effects of Varenicline Compared With Nicotine Replacement Therapy on Long Term Smoking Cessation and Clinically Important Outcomes?
• Self-Assessment Method for Statin Side-effects Or Nocebo
• Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)
• A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
• Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent
• Technological Platforms and Telerehabilitation in Heart Surgery
• Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial
• General Anesthesia for Endovascular Thrombectomy; A Pilot Study.
• Naltrexone/Bupropion Cardiovascular Outcomes Study
• A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Male Subjects
• Oxidative Stress and Oxysterols Profiling in Patients With Carotid Revascularization
• Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting
• Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C)
• Secondary Prevention of Cardiovascular Disease in the Elderly Trial
• Hunting for the Off-Target Properties of Ticagrelor on Endothelial Function in Humans (HI-TECH)
• Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD
• To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male Volunteers
• FEIBA and Use of Blood Products in Cardiac Surgery
• Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study
• Physiologic Interactions Between the Adrenal- and the Parathyroid Glands
• Specified Drug Use-results Survey of Betanis Tablets for Patients With Coexisting Cardiovascular Disease
• Changes in Myocardial Biomechanics and Early Short-term Doxycycline Therapy in Patients With Primary Anterior STEMI
• Antiplatelet Therapy in HIV
• Bococizumab HIV Evaluation (B-HIVE) Study
• High Potency Statins and the Risk of Diabetes
• Exercise and Pharmacotherapy for Anxiety in Cardiac Patients
• Ticagrelor vs. Prasugrel Effects on Infarct Size
• Liver Function Measured by HepQuant-SHUNT in the Prediction of Outcomes in Patients With Heart Disease
• Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects
• Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonists
• eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients
• Cardiovascular Risk in HIV Patients on Antiretroviral Therapy Therapy: The MHEART Study
• Remifentanil Anesthesia and Postoperative BIS in Cardiac Surgery
• Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular Disease
• Length of Effect of Extended Release Aspirin on Platelets in Patients With Diabetes and Heart Disease
• Rhode Island Diastolic Dysfunction - Heart Failure
• Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
• Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk
• Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention
• Micardis® / MicardisPlus® Program for Therapy Optimization With Telmisartan in Cardiovascular Diseases (PROTEKT)
• Living With Statins - The Impact of Cholesterol Lowering Drugs on Health, Lifestyle and Well-being
• Relative Bioavailability Study of Candesartan Cilexetil Under Fasting Conditions
• Metformin in Kidney Disease
• Enhancement of Brown Adipose Tissue Function Via Chronic Pharmacological Treatment
• The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients
• Biomarker Guided Therapies in Stage A/B Heart Failure
• Phophate Lowering Trial
• Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in High Risk for Cardiovascular Disease
• Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery
• Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients
• Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U)
• VITAL Rhythm Study
• Microvascular and Antiinflammatory Effects of Rivaroxaban Compared to Aspirin in Type-2 Diabetic Patients With Cardiovascular Disease
• Search of Biomarkers of Mineralocorticoid Receiver Activity : the Value of Neutrophil Gelatinase Associated Lipocalin (NGAL)in Serum or Urine in Human
• Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
• Nitric Oxide Bioavailability and Early Life Stress (NO-Stress)
• The Effect of Pomegranate Juice (PJ) on Oxidative Stress Biomarkers During Treatment With IV Iron During One Dialysis Session
• Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia
• Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management
• LIPT - Liraglutide in Polycystic Ovary Syndrome
• Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring
• Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Mul
• Levosimendan Versus Dobutamine in Cardiopatic Patients Undergoing Major Non Cardiac Surgery
• Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCI
• Efficacy of EVP 1001-1 (SeeMore) in the Assessment of Myocardial Viability in Patients With Cardiovascular Disease
• ISCHEMIA-Chronic Kidney Disease Trial
• BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
• Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes
• The Effects of Enzymes and Flavonoids on Inflammation and Coagulation After Marathon
• Study of Adalimumab to Lower Cardiovascular Risk in RA Patients With Well Controlled Joint Disease
• Determining the Effect of Abacavir on Platelet Activation
• GH and Cardiovascular Risk Factors
• Vascular Inflammation in Psoriasis - Extension Study
• Risk Factor Control Before Orthopedic Surgery
• A Study of Evacetrapib (LY2484595) in Participants With Severe Renal Impairment and in Healthy Participants
• Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy
• Does Rosuvastatin Delay Progression of Atherosclerosis in HIV
• Omega 3 FA Supplements as Augmentation in the Treatment of Depression
• The Canadian HIV Quit Smoking Trial: Tackling the Co-morbidities of Depression and Cardiovascular Disease in HIV+ Smokers
• The Elderly ACS II Trial
• Ekvasis of Atorvastatin (Antorcin®) Treatment in Patients With Acute Cardiovascular Events
• Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery
• Does Deficiency in Vitamin D Induced Hypercoagulation or Thrombin Generation
• Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients
• Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy
• Vitamin K1 to Slow Progression of Vascular Calcification in HD Patients
• Statin Therapy in Young Adult Survivors of Childhood Cancer
• CARNIVAL Study: Gut Flora Dependent Metabolism of Dietary CARNItine and Phosphatidylcholine and cardioVAscuLar Disease
• A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities
• Evaluation Of Switching From Twice Daily Tacrolimus To Once Daily Formulation On Cardiovascular Risk
• Multi-centre Clinical Trial on Hormone Replacement Treatment in China
• A Study of Evacetrapib in High-Risk Vascular Disease
• A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats
• Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis
• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab
• The International Polycap Study 3 (TIPS-3)
• Effect of the Aquaretic Tolvaptan on Nitric Oxide System (TORA)
• Efficacy and Safety Study of Sodium Tanshinone IIA Sulfonate on Pulmonary Hypertension
• Study of Cardiovascular Disease and Obstructive Sleep Apnea
• Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Ri
• Anti-INFLammatory to Address Mood and Endothelial Dysfunction (INFLAMED)
• Reducing Cardiovascular Disease by Combining Smoking Cessation Pharmacotherapy and Behavioural Counseling
• Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
• Physiological Study of Human Cholesterol Metabolism and Excretion
• Cardiovascular Inflammation Reduction Trial
• MARCH Vascular Endothelium Substudy
• Efavirenz Versus Rilpivirine on Vascular Function, Inflammation, and Oxidative Stress
• Safety and Effectiveness of Intra-coronary Nitrite in Acute Myocardial Infarction
• A Clinical Trial for People HIV+ Age > 50 at Risk for Heart Disease
• Assessment of the Role of the Growth Hormone (GH) Onthe Intestinal Triglyceride-rich-lipoproteins (TRL) Metabolism
• Evaluation of Exercise Treadmill Test (ETT) Indices in Participants With Cardiovascular Disease
• Vascular Inflammation in Psoriasis Trial (The VIP Trial)
• Effectiveness of Sitagliptin for HIV Insulin Resistance and Inflammation
• Hydroxychloroquine in Cardiovascular Disease in Patients With Chronic Kidney Disease: A Proof of Concept Study
• The Effect of Morphine on Prasugrel Absorption in STEMI Patients
• Ulinastatin's Anti-inflammatory Reaction in Cardiac Surgery
• A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
• Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Body Mass Index ≥ 27
• The Evening Versus Morning Polypill Utilization Study
• A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major
• Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505
• International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)
• Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2)
• A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic
• Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
• A Trial of Tadalafil and Glycemic Traits
• Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention
• The Metformin in Coronary Artery Bypass Graft (CABG) (MetCAB) Trial
• Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients
• Effects of Exercise Training and AGE-crosslink Breaker on Cardiovascular Structure and Function
• [E]PANOVA Combined With a [S]TATIN in [P]ATIENTS With HYPERT[R]IGLYCER[I]DEMIA to Reduce Non-HDL CHOLES[T]EROL
• Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
• Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal General Surgery
• Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal (Urology,Obstetrics,Gynecology)
• Drug Use Investigation for FLOLAN (Epoprostenol) Injection 0.5mg・1.5mg
• Aspirin in Reduction of Tension II Study
• Primary Prevention of Cardiovascular Disease (CVD) in Pre-diabetic & Pre-hypertensive Subjects
• Gastric Bypass Versus Best Medical Treatment on Progression of Carotid-intima Media Thickness in Type 2 Diabetes Mellitus (T2DM)
• Pilot Study of Using Copeptin to Predict Response to Tolvaptan
• Evaluating Additional Platelet Inhibition in Patients With High Platelet Reactivity Undergoing Percutaneous Coronary Intervention
• Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type 1 DM and Diabetic Nephropathy
• Safety and Feasibility of an Endotoxemia Model
• Polypill Effects on Sub Clinical Atherosclerosis (PESCA) Trial
• Normal Oxygenation Versus Hyperoxia in the Intensive Care Unit (ICU)
• Single Pill to Avert Cardiovascular Events
• Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
• Lipid Efficacy of the Extended Release Niacin/Laropiprant Combination in Patients With Cardiovascular Disease
• High Dose and Low Dose of Atorvastatin in Patients With Unstable Angina and NSTEMI (Non ST Elevation MI)
• Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers - Protocol 4
• Can Dipyridamole Induce Protection Against Ischemia and Reperfusion Injury in Patients Undergoing Elective Coronary Artery Bypass Grafting (CABG)?
• The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia
• Effect of Selective and Nonselective Cyclooxygenase Enzyme Inhibition on Arterial Blood Pressure and Cerebral Blood Flow With Exposure to Intermittent Hypoxia in Humans
• Prevention of Cardiovascular Disease in Middle-aged and Elderly Iranians Using a Single PolyPill
• A Study to Evaluate the Safety, Tolerability, and Activity of Intravenous MLDL1278A in Patients on Standard-of-Care Therapy for Stable Atherosclerotic Cardiovascular Disease (GLACIER)
• Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART.
• REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification
• Prevention of Cardiovascular Disease Using a Single PolyPill in an Urban Population - Focus on Liver-Related Variables.
• Pharmacokinetics of Dabigatran Etexilate (Pradaxa®) During Haemodialysis
• The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan
• The Effects of Atorvastatin on the Nitric Oxide-system in Healthy Young Man
• The Effects of Atorvastatin on the Nitric Oxide-system in Patients With Non-diabetic Nephropathy
• Mycophenolate Mofetil for Reducing Cardiovascular Risk in Renal Transplant Recipients
• The Effects of Atorvastatin on the Nitrogen Oxide-system in Patients With Type 2 Diabetes and Nephropathy
• Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Abnormalities in Latin America
• Vitamin D and Omega-3 Trial (VITAL)
• Novel Pathways to Manage Inflammation and Atherosclerosis in Dialysis Patients: Role of Nicotinic Acid
• Vitamin D and Inflammatory Markers of Cardiovascular Disease in African Americans With Type 2 Diabetes
• Evaluation of Oral Alpha-Cyclodextrin for Decreasing Serum Cholesterol
• Effect of Estradiol+Drospirenone Versus Estradiol+MPA on Endothelial Function
• Evaluating the Efficacy and Safety of Dehypotin® in the Patients With Type 2 Diabetes Mellitus or Cardiovascular Disease
• Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
• The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis
• PeriOperative ISchemic Evaluation-2 Trial
• A Trial of Telmisartan Prevention of Cardiovascular Disease
• A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
• UMPIRE - Use of a Multidrug Pill In Reducing Cardiovascular Events
• HIV Treatment and CVD Events
• Fenofibrate and Omega-3 Fatty Acid Modulation of Endotoxemia
• Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease
• PK Study of IV Formulation of GW856553
• Effects of Lipemia and Metformin on Endothelial Function
• ROS Signaling in Endothelial Function
• CANVAS - CANagliflozin cardioVascular Assessment Study
• Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and Hypertension
• Dyslipidemia in Cardiovascular Disease
• A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
• Doxycycline Outcomes in Lupus Erythematosus
• Feasibility Study of Omega-3 Fatty Acids in Dialysis Patients
• An Open-label Single Dose Randomized, Parallel Group Study Followed by Single-blind Repeat Dosing, to Compare the Relative Bioavailability of GSK2212836.
• Study On Liprimar (Atorvastatin) In Patients With Coronary Heart Disease (CHD) And High Risk Of Cardiovascular Complications
• Effect of Rosuvastatin on Endothelial Function
• Cardiovascular Prevention for Persons With HIV
• Interaction in Chronic Obstructive Pulmonary Disease Experiment
• Effects of 3 Months of Selective Serotonin Reuptake Inhibitor (SSRI)-Treatment on Metabolism and Hypothalamic-pituitary-adrenal (HPA)-Axis in Young Men Born With Low Birth Weight
• Diuretics and Angiotensin-Receptor Blocker Agents in Patients With Stage I Hypertension
• Hypertension Prevention in Pre-Hypertensive Individuals
• Cardiovascular Magnetic Resonance for the Occluded Infarct-Related Artery Treatment
• Statin Therapy to Improve Atherosclerosis in HIV Patients
• Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries
• Ex Vivo Human Thrombosis Chamber Study
• Inflammation in Chronic Kidney Disease and Cardiovascular Disease - The Role of Genetics and Interleukin-1 Receptor Antagonist (IL-1ra)
• Effect of Exercise or Metformin on Nocturnal Blood Pressure and Other Risk Factors for CVD Among Obese Adolescents
• Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
• Effect of ACE-inhibitors on Aortic Stiffness in Elderly Patients With Chronic Kidney Disease
• Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease
• Pentoxifylline and Combination Antiretroviral Therapy to Improve Blood Vessel Function in HIV-Infected People
• Ezetimibe/Simvastatin (MK-0653A) Versus Rosuvastatin Versus Doubling Statin Dose in Participants With Cardiovascular Disease and Diabetes Mellitus (MK-0653A-133)(COMPLETED)
• PeriOperative ISchemic Evaluation-2 Pilot
• Heme Oxygenase (HO) Activity and Adenosine Induced Vasodilation
• Is Augmentation of PORH by Rosuvastatin Adenosine-receptor Mediated?
• Study of Post-meal Blood Sugar Peaks in Association With Vascular Disease in Childhood Obesity
• Differential Intervention Trial by Standard Therapy Versus Pitavastatin in Patients With Chronic Hemodialysis (DIALYSIS)
• The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young Adults
• Effect of Maraviroc on Endothelial Function in HIV-Infected Patients
• Effect of Raltegravir on Endothelial Function in HIV-Infected Patients
• Regulation of Lipoprotein Transport in Metabolic Syndrome
• Effects of Phosphate Binding With Sevelamer in Stage 3 Chronic Kidney Disease
• Evaluating the Effectiveness of Pentoxifylline at Improving Blood Vessel Function in HIV-infected People Not Receiving Antiretroviral Medications
• Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial
• Safety and Efficacy Study of KAI-9803 to Treat Subjects With ST Elevation Myocardial Infarction [Heart Attack]
• Anti-Inflammatory and Anti-Platelet Effect of Clopidogrel and Aspirin vs Aspirin Alone in Symptomatic Polyvascular Disease and in Patients With Multiple Recurrent Cardiovascular Events
• Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease
• Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol
• Platelet Hyperreactivity to Aspirin and Stroke
• Periodontal Disease and Cardiovascular Disease
• Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment
• Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Mixed Hyperlipidemia and Two or More Risk Factors
• Vytorin on Carotid Intima-media Thickness and Overall Rigidity
• Vitamin D, Insulin Resistance, and Cardiovascular Disease
• Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases.
• Double-Blind, Randomized, Placebo-Controlled Trial of MLN1202 on C-Reactive Protein Levels in Patients With Risk Factors for Cardiovascular Disease
• Does Simvastatin Affect Insulin Sensitivity in Dyslipidemic Type 2 Diabetic Patients?
• Statin Therapy for Ischemic and Nonischemic Cardiomyopathy
• Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention Trial
• Endothelial Effects of Basal Insulin: Detemir Versus Glargine
• Effect of Homocysteine-Lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Endothelium-Dependent Vasodilatation of Forearm Resistance Vessels in Patients With Coronary Heart Disease
• Immune Effects of Vitamin D in Hemodialysis Patients
• Comparison of Vascular Findings Between Symptomatic and Asymptomatic Postmenopausal Women Before and During Hormone Therapy (HRT)
• Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome
• Study To Assess The Efficacy Of A Cholesterol Lowering Drug On Top Of Statins In Patients After Myocardial Infarction (MI)(0653A-150)
• REsearching Coronary REduction by Appropriately Targeting Euglycemia (RECREATE Pilot Study)
• Exercise and Pioglitazone for HIV-Metabolic Syndromes
• INSTANT: INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial
• Pharmacological Regulation of Fat Transport in Metabolic Syndrome
• Effect of a PPAR-Alpha Agonist on the Age Related Changes in Myocardial Metabolism and Mechanical Function
• A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice
• Targeting Inflammation Using Salsalate in CardioVascular Disease
• Role of Nitric Oxide in the Impact of Aging on Myocardial Remodeling
• Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease
• Sodium Thiosulfate Treatment of Vascular Calcification in ESRD
• Effect of Apple Flavanols on Risk of Cardiovascular Disease
• Polypill For Prevention of Cardiovascular Disease
• A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients
• PPAR-gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease
• Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases)
• A Study Investigating Blood Concentrations Of Rosuvastatin When Co-administered With GW856553 In Healthy Men
• An Exploratory Sub-study for the RED-HF™ (Reduction of Events With Darbepoetin Alfa in Heart Failure) Trial
• Enteric Coating as a Factor in Aspirin Resistance
• Effects of Angiotensin Receptor Antagonist on Prohibiting Cardiovascular Events on Hemodialysis Patients
• Effects of Achieving Very Low LDL-Cholesterol After Treatment With Statins on Steroidogenesis and Cognition
• The Water-Blueberry Study
• Oslo Antioxidant Study
• Targeting Peroxisome Proliferator-activated Receptor-gamma in Peritoneal Dialysis Patients - Will it Reduce Inflammation, Atherosclerosis, Calcification and Improve Survival of Peritoneal Dialysis Patients?
• Lovaza's Effect on the Activation of Platelets
• Effect of the Plantago Ovata Husk on the Lipid Profile of Patients With Hypercholesterolemia
• Pharmacodynamic Trial, of Slow Release ASA, in Platelet Functionalism, a Long Term Treatment Period
• A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease
• Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease in Hemodialysis Patients
• Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart Disease
• Effects of Growth Hormone on the Nitric Oxide Pathway
• Reduction of Smoking in Cardiac Disease Patients
• Heart Outcomes Prevention Evaluation-3
• Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE
• Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer
• Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)
• Cholesterol and Pharmacogenetic Study
• Safety and Efficacy Study of AVI-5126 When Used on Vein Grafts Before Use in Heart by-Pass Graft Surgery (CABG)
• Efficacy and Safety of Natto Extract
• The Indian POLYCAP Study (TIPS)
• Randomized Clinical Trial of Adipose-Derived Stem Cells in the Treatment of Pts With ST-elevation Myocardial Infarction
• Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?
• Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?
• Pharmacodynamic-pharmacokinetic Trial, of Slow Release ASA, in the Platelet Functionalism.
• Prevention of Cardiac and Vascular Events in Patients With NGT/IGT.
• Growth Hormone's Effect on Endothelial Progenitor Cells
• Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122)
• ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
• Midlife Cholesterol Study
• RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
• Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin Monotherapy
• Evaluation of Atorvastatin Treatment on Carotid Plaque.
• Salsalate Therapy to Reduce Insulin Resistance and Cardiovascular Risk
• A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels
• Intensive Glycemic Control and Skeletal Health Study
• Risk and Prevention Study: Evaluation of the Efficacy of n-3 PUFA in Subjects at High Cardiovascular Risk
• Uremic Hyperhomocysteinemia -A Folate Trial for Possible Prevention of Cardiovascular Events
• Endothelial Function in a Sample Group of Patients From the ICARE Study
• Use of Beta Blockers in Elderly Trauma Patients
• The STRETCH Study: Distensibility on Endothelial-Dependent Vasoreactivity in Subjects With Systolic Hypertension
• Omacor and Placebo in Carotid Plaque Stability
• Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
• L-Arginine in the Treatment of Peripheral Arterial Disease
• Efficacy and Safety of Varenicline in Smokers With Cardiovascular Disease Who Wish to Quit Smoking
• Intravenous Allopurinol to Improve Heart Function in Individuals With Dilated Cardiomyopathy
• STRETCH Study: Effect of Distensibility on Endothelial-Dependent Vasoreactivity in Patients With ISH
• Aspirin Dose and Atherosclerosis in Patients With Heart Disease
• Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome
• Conditioned Placebo Effects and Treatment of Hypertension
• Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes
• Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I)
• Effects of Mycophenolate Mofetil (MMF) on Surrogate Markers for Cardiovascular Disease in HIV-1 Infected Patients
• Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV
• Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia
• Reducing Total Cardiovascular Risk in an Urban Community
• Uric Acid and Hypertension in African Americans
• Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease
• Effect of Paroxetine on COAT-Platelet Production in Normal Volunteers and Patients With Cardiovascular Disease
• Pravastatin for Hyperlipidaemia in HIV.
• Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation
• The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia
• Prevention of Cardiovascular Complications in Diabetic Patients With Vitamin E Treatment
• Effects of Citalopram on Hostility and CHD Risk
• Homocysteine Lowering and Atherosclerosis Reduction Trial (HART)
• Oral Contraceptives in the Metabolic Syndrome
• Citrulline for Children Undergoing Cardiopulmonary Bypass Surgery
• HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)
• Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects
• Raloxifene Use for The Heart
• Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease
• Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass.
• Selenium Supplementation in Chronic Obstructive Pulmonary Disease (COPD) Patients
• Olmesartan Medoxomil in Atherosclerosis
• Olmesartan Medoxomil in Diabetes Mellitus
• POISE Trial: Perioperative Ischemic Evaluation Study
• Bupropion for Hospitalized Smokers With Acute Cardiovascular Disease
• VIP: Vascular Imaging Project. Study on the Progression of Cardiovascular Disease in Renal Transplant Recipients
• A Phase II Optimization Study of BMS068645 and Sestamibi Planar Imaging
• Atorvastatin Versus Simvastatin In The Prevention Of Coronary Heart Disease (CHD) In Patients With Known CHD
• Intravenous Pantoloc In Aspirin-Induced Ulcer Bleeding
• Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis Patients
• Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placeb
• Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke
• Stop Atherosclerosis in Native Diabetics Study
• China Salt Substitute Study
• China Plant Sterol Trial
• The Study of Atherosclerosis With Ramipril and Rosiglitazone
• Chinese Community Smoking Cessation Project
• Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide Diuretics in Hypertensive Patients
• OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study
• Claudication: Exercise Versus Endoluminal Revascularization (CLEVER)
• Trial of Pulse Steroid Therapy in Kawasaki Disease--Pediatric Heart Network
• High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the Elderly
• Warfarin and Antiplatelet Vascular Evaluation
• Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients
• Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine
• Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery
• Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose Intolerance
• The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease
• Niacin Plus Statin to Prevent Vascular Events
• Tea's Effect on Atherosclerosis Pilot Study (TEA Study)
• Electrophysiological Effects of Late PCI After MI
• Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors
• Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases
• Fluoxetine as a Quit Smoking AID for Depression Prone
• Preventing Weight Gain and Controlling Blood Pressure During Smoking Cessation in Hypertensive Smokers
• The Use of Nesiritide in Thoracic Aneurysm Repair to Prevent Acute Renal Failure
• HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)
• Study of the Tolerability, Pharmacokinetics, and Pharmacodynamics of INS50589 Intravenous Infusion in Healthy Volunteers
• The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial
• Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
• Effectiveness of Depression Treatment Following Coronary Artery Bypass Surgery
• IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.
• Estrogen, HDL, and Coronary Heart Disease in Women
• Use of Nesiritide in the Management of Acute Diastolic Heart Failure
• Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions
• Comparing Angiomax to Heparin With Protamine in Patients Undergoing Cardiopulmonary Bypass (CPB)
• Angiomax in Patients With HIT/HITTS Type II Undergoing CPB
• Dobutamine Echocardiography In Patients With Ischemic Heart Failure Evaluated for Revascularization
• Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
• A Trial of CS-747 (Prasugrel) Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI)
• ACE Inhibition and Novel Cardiovascular Risk Factors
• Stop Atherosclerosis in Native Diabetics Study
• Nevada Environmental Tobacco Smoke and Health Study
• Estrogen, Cytokines and Heart Failure in Women
• Effects of Magnesium on Individuals Undergoing Coronary Artery Bypass Graft Surgery
• Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers
• Phase II Study To Evaluate The Safety and Efficacy of Hemoglobin Raffimer in Patients Undergoing First Time CABG Surgery
• Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates
• Comparison of Surgical and Medical Treatment for Congestive Heart Failure and Coronary Artery Disease
• Anticoagulation, Vitamins, and Endothelial Function
• Effects of Herbal Antioxidants on Cardiovascular Disease in Older Blacks
• Effect of High Dose Vitamin E on Carotid Atherosclerosis
• Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes
• Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis
• Genetic Epidemiology of Responses to Antihypertensives
• Occluded Artery Trial (OAT)
• Study of Inherited Changes of Receptors Located on Blood Vessels
• Action to Control Cardiovascular Risk in Diabetes (ACCORD)
• Azithromycin and Coronary Events Study (ACES)
• Prevention of Recurrent Venous Thromboembolism (PREVENT)
• CVD Risk and Health in Postmenopausal Phytoestrogen Users
• Soy Estrogen Alternative Study (SEA)
• Women's Health Initiative (WHI)
• Magnesium in Coronaries (MAGIC)
• Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
• Estrogen and Graft Atherosclerosis Research Trial (EAGER)
• Postmenopausal Hormone Therapy in Unstable Angina
• Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up
• Cholesterol-Lowering Atherosclerosis Study (CLAS)
• NHLBI Type II Coronary Intervention Study
• Beta-Blocker Evaluation in Survival Trial (BEST)
• Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)
• Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)
• Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
• Women's Angiographic Vitamin and Estrogen Trial (WAVE)
• HDL-Atherosclerosis Treatment Study (HATS)
• Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.
• Estrogen Replacement and Atherosclerosis (ERA) in Older Women
• Enalapril After Anthracycline Cardiotoxicity
• Oral Calcium in Pregnant Women With Hypertension
• Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
• Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)
• Arterial Disease Multifactorial Intervention Trial (ADMIT)
• Calcium for Pre-Eclampsia Prevention (CPEP)
• Antiarrhythmics Versus Implantable Defibrillators (AVID)
• Raynaud's Treatment Study (RTS)
• Tamoxifen Study
• Recurrent Carotid Stenosis
• Cardiac Arrhythmia Suppression Trial (CAST)
• Diuretics, Hypertension, and Arrhythmias Clinical Trial
• Myocarditis Treatment Trial
• Treatment of Mild Hypertension Study (TOMHS)
• Prevention of Coronary Aneurysms in Kawasaki Syndrome
• Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)
• Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)
• Studies of Left Ventricular Dysfunction (SOLVD)
• Systolic Hypertension in the Elderly Program (SHEP)
• Trial of Antihypertensive Intervention Management
• Familial Atherosclerosis Treatment Study
• Platelet-Inhibitor Drug Trial in Coronary Angioplasty
• Intravenous Streptokinase in Acute Myocardial Infarction
• Thrombolysis in Myocardial Infarction (TIMI)
• Cardiac Arrhythmia Pilot Study (CAPS)
• Randomized Clinical Trial of Non-Surgical Reperfusion of the Coronary Arteries
• Hypertension Prevention Trial (HPT) Feasibility Study
• Physicians' Health Study
• Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study)
• Control of Hypertension by Non-Pharmacologic Means
• Platelet Drug Trial in Coronary Disease Progression
• Management of Patent Ductus in Premature Infants
• Multicenter Investigation of Limitation of Infarct Size (MILIS)
• Beta-Blocker Heart Attack Trial (BHAT)
• Aspirin-Myocardial Infarction Study (AMIS)
• Lipid Research Clinics Coronary Primary Prevention Trial (CPPT)
• Multiple Risk Factor Intervention Trial for the Prevention of Coronary Heart Disease (MRFIT)
• Hypertension Detection and Follow-up Program (HDFP)
• Treatment of Hypertension
• Coronary Drug Project Mortality Surveillance
• Coronary Drug Project
• Multicenter Unsustained Tachycardia Trial (MUSTT)
• Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer
• Asymptomatic Cardiac Ischemia Pilot (ACIP) Study
• Cholesterol Reduction in Seniors Program (CRISP)
• Digitalis Investigation Group (DIG)
• Do Fish Oils Prevent Restenosis Post-Coronary Angioplasty?
• Thrombolysis in Myocardial Ischemia Trial (TIMI III)
• Asymptomatic Carotid Artery Plaque Study (ACAPS)
• Myocardial Infarction Triage and Intervention Project (MITI)
• Postmenopausal Estrogen/Progestin Interventions (PEPI)
• Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)
• Post Coronary Artery Bypass Graft (CABG) Study
• Harvard Atherosclerosis Reversibility Project (HARP)